GUILD Learning and Development has announced the creation of a new CPD accredited module for pharmacists, titled 'Improving the injecting experience for patients using insulin'.
Supported by an unrestricted educational grant from BD (Becton Dickinson), the module describes the challenges faced by people with type 1 and type 2 diabetes, including the commencement of insulin therapy and some of the common adverse events.
Accredited for two hours of Group 1 CPD, the course can be accessed via myCPD.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Oct 17
